Xiang Xu

10.9k total citations · 2 hit papers
290 papers, 7.6k citations indexed

About

Xiang Xu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiang Xu has authored 290 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 51 papers in Immunology and 38 papers in Cancer Research. Recurrent topics in Xiang Xu's work include Mesenchymal stem cell research (20 papers), Cancer-related molecular mechanisms research (16 papers) and RNA modifications and cancer (15 papers). Xiang Xu is often cited by papers focused on Mesenchymal stem cell research (20 papers), Cancer-related molecular mechanisms research (16 papers) and RNA modifications and cancer (15 papers). Xiang Xu collaborates with scholars based in China, United States and Hong Kong. Xiang Xu's co-authors include Ya‐Lin Sun, Timothy Hoey, Simon Geir Møller, Keith Williamson, Wei Xing, Yu Yang, Wei Guo, Luoquan Ao, Gang Chen and Xiang Ao and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Xiang Xu

274 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?

2022 349 citations Meng Kou, Li Huang et al. Cell Death and Disease profile →
METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer

2022 276 citations Yu Yang, Luoquan Ao et al. profile →

Peers

Countries citing papers authored by Xiang Xu

Since Specialization

Citations

This map shows the geographic impact of Xiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Xu more than expected).

Fields of papers citing papers by Xiang Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Xu. The network helps show where Xiang Xu may publish in the future.

Co-authorship network of co-authors of Xiang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Xu. A scholar is included among the top collaborators of Xiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Xu. Xiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High‐resolution Performance of Leaning Pillar[6]arene Functionalized with Imidazolium Ionic Liquids for Gas Chromatography 2025 ·Chemistry & Biodiversity ·Yuanyuan Zhang, Haixin Liu, Xiang Xu, Xiaoli Shen, (unknown), (unknown), Ming You, Tao Sun, Zhiqiang Cai, Xiaoyan Zhang	0
2	CTC-neutrophil interaction: A key driver and therapeutic target of cancer metastasis 2024 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), Jie Lou, (unknown), Qingqing Yang, Xiang Xu, Xing Zhou	12
3	Minocycline‐Loaded Cerium Oxide Nanoparticles for the Enhanced Treatment of Intracerebral Hemorrhage 2024 ·Advanced Functional Materials ·Xiang Xu, Zhihui Han, Dong Li, Xingshun Xu, Yaobo Liu, Cong Cao, (unknown), Jian Cheng, John H. Zhang, Liang Cheng, Gang Chen	18
4	Lactoferrin-modified nanoemulsions enhance brain-targeting and therapeutic efficacy of arctigenin against Toxoplasma gondii-induced neuronal injury 2024 ·International Journal for Parasitology Drugs and Drug Resistance ·(unknown), (unknown), Xin Yan, (unknown), Xinyu Shen, (unknown), Yiming Liu, Jinyi Zhou, (unknown), (unknown), Xiang Xu, Lian Xun Piao	2
5	Cepharanthine triggers ferroptosis through inhibition of NRF2 for robust ER stress against lung cancer 2024 ·European Journal of Pharmacology ·Xiaofeng Bai, (unknown), Meifang Wang, Liu‐Gen Li, Ning Han, (unknown), Nannan Chen, (unknown), (unknown), Xiao Wang, Xiang Xu, Tingting Yu, Tong‐Fei Li, (unknown)	8
6	Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10 2024 ·Neoplasia ·Min He, Xiang Ao, Yu Yang, Yanmin Xu, Tao Liu, Luoquan Ao, Wei Guo, Wei Xing, Jing Xu, Qian Cheng, Jianhua Yu, Xiang Xu, Ping Yi	4
7	Cuproptosis-based layer-by-layer silk fibroin nanoplatform-loaded PD-L1 siRNA combining photothermal and chemodynamic therapy against metastatic breast cancer 2024 ·Materials Today Bio ·Zheng Li, Lan Cheng, Xiang Xu, Rui Jia, (unknown), Qian Zhang, Guotao Cheng, (unknown), Zulan Liu, Xiaoling Tong, Bo Xiao, Fangyin Dai	8
8	Lactate-mediated lactylation in human health and diseases: Progress and remaining challenges 2024 ·Journal of Advanced Research ·Xueting Hu, Xiaofeng Wu, Jinyi Xu, Xiang Xu	14
9	Separation performances of extended pillar[6]arenes, a new stationary phase for gas chromatography 2024 ·Talanta ·Tao Sun, Yuanyuan Zhang, Haixin Liu, Xiang Xu, Zhiqiang Cai, Shaoqiang Hu, Xianming Liu, Maurizio Quinto, Shusheng Zhang	3
10	Association between physical activity and visceral adiposity index (VAI) in U.S. population with overweight or obesity: a cross-sectional study 2024 ·BMC Public Health ·(unknown), Xiang Xu, (unknown), Qiankun Yang, Taotao Yang, Xiang Zhou, Hao Xue, (unknown), Fei Luo	8
11	The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment 2023 ·Frontiers in Immunology ·Weiqiang Li, Qianqian Liu, (unknown), Xiang Xu, (unknown)	47
12	Protective effect of arctiin against Toxoplasma gondii HSP70-induced allergic acute liver injury by disrupting the TLR4-mediated activation of cytosolic phospholipase A2 and platelet-activating factor 2023 ·International Immunopharmacology ·(unknown), Xiang Xu, Fumie Aosai, Mingyue Zhang, Lulu Zhou, Lian Xun Piao	6
13	Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? breakdown → 2022 ·Cell Death and Disease ·Meng Kou, Li Huang, (unknown), (unknown), Shaoxiang Chen, Jie Liu, Liyan Guo, Xiaoxian Zhang, Xiaoya Zhou, Xiang Xu, Xiaomei Yan, Yan Wang, Jinqiu Zhang, Aimin Xu, Hung‐Fat Tse, Qizhou Lian	349
14	New role of sertraline against Toxoplasma gondii ‐induced depression‐like behaviours in mice 2021 ·Parasite Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Cheng Hua Jin, Juan Ma, Xuejun Jin, Xiang Xu, Lian Xun Piao	9
15	Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma 2020 ·SHILAP Revista de lepidopterología ·Yanxi Pei, Xin Lou, (unknown), Xiang Xu, (unknown), Donghua Xu, Zhao Yang, (unknown), Dawei Zhang	2
16	The prognostic value of combining CD133 and mismatch repair proteins in patients with colorectal cancer 2020 ·Clinical and Experimental Pharmacology and Physiology ·Xiaohui Wang, Wei Qiu, Haoyu Liu, (unknown), Hua Ye, (unknown), Xiang Xu, Ping Chen	7
17	Long Noncoding RNA (lncRNA) MT1JP Suppresses Hepatocellular Carcinoma (HCC) in vitro 2020 ·SHILAP Revista de lepidopterología ·(unknown), Yong Dai, Jianjun Chen, Linhui Liang, Sheng Xu, Xiang Xu	1
18	2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Xiangdong Guan, (unknown), Ling Zeng, Xiang Xu, (unknown), Hongbo Liu	4
19	Downregulated expression of RACK1 results in pancreatic cancer growth and metastasis 2019 ·SHILAP Revista de lepidopterología ·Li Zhang, Yue Lv, Yefei Rong, Weichang Chen, Yuanzhang Fang, (unknown), (unknown), Dayong Jin, Xiang Xu	2
20	Ureteral metastasis of non-small-cell lung cancer: a case report 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Xiang Xu, Hao Zhang, (unknown), Jianjun Liu, Jian Chen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact